- May 06, 2021Source: Healthcare In Europe
The promise and reality about AI for interventional oncology
- April 16, 2019
Interventional Radiologists Perez Lozada and Marino Create First Endovascular Fistula in Connecticut
- March 14, 2019
New Treatment to Remove Clots Offers Dramatic Results
- February 18, 2019
Yale First in Connecticut to Offer Advanced Cardiac Test
- December 03, 2018
Yale Establishes Tanzania Interventional Radiology Initiative
Interventional Radiology
General Information
P.O. Box 208042, South Pavilion 2-213
New Haven, CT 06520-8042 Admin Assistant,Lori Raccio |
Phone:
Fax: |
203-785-4747
203-737-1077 |
Yale Interventional Radiology consists of a division of physicians specializing in the use of imaging modalities to guide the performance of minimally invasive diagnostic and therapeutic procedures in numerous parts of the body. Additionally, we are closely allied with Yale Vascular Surgery in a Yale Vascular Center, especially in the evaluation and treatment of arterial and venous blockages and aneurysms, including newer methods for angioplasty, the removal of material causing arterial blockage, and stent-grafts for aneurysms.
Clinical Interests
Other clinical interests include embolization for uterine fibroids, vascular anomalies, and pelvic congestion syndrome and varicoceles; minimally invasive treatment of cancer using embolization (including chemoembolization) and local treatments such as radiofrequency ablation; the management of varicose veins; interventions in bile ducts and the urinary track; and the placement of a variety of venous access devices.
Through the Yale Vascular Malformation Center, we are a world leader in the evaluation and treatment of patients with hereditary hemorrhagic telangiectasia (HHT, or Osler-Weber-Rendu syndrome).
Yale Interventional Radiologists see patients at our office in the Yale Physicians’ Building on Howard Avenue and perform procedures at Yale-New Haven Hospital and at the Veterans Administration Medical Center. In addition, we are active in training residents and fellows and conduct research.
Research Direction
- Outcome of embolotherapy for pulmonary arteriovenous malformations
- Transjugular intrahepatic portosystemic shunts
- Locoregional therapy for hepatocellular carcinoma
- Outcome after uterine fibroid embolization
- Carotid artery stenosis
- Thrombolytic spects and applications
- CT angiography of peripheral vascular disease
- Dynamic vascular imaging
- Clinical applications of phase contrast imaging
- Hemodialysis access catheters
- Endovascular surgery
- Stent technology
- Vascular imaging: improving vascular outcomes
- Fenestrated endografts; branched endografts
- Embolotherapy technics
- Vascular malformations
- Male infertility
- Pelvic congestion syndrome and fibroid disease
- Hereditary Hemorrhagic Telangiectasia
Yale Interventional Oncology Research Lab
Yale IR offers a unique research environment that encompasses the full gamut of basic, translational and clinical science, including clinical trials. Our NIH-funded science focuses on topics such as drug delivery, novel molecular targeted imaging and therapeutics, artificial intelligence and advanced intra-procedural navigation systems. We collaborate with partners in immunobiology, biomedical engineering and biophysics and have the most advanced experimental imaging equipment at our disposal, including a fully equipped state-of-the art Philips Allura Clarity C-Arm Interventional Suite. Our group has a track record of fostering careers of excellent IR trainees and junior faculty. Previous researchers and physician-scientists in IR won numerous national and international research prizes, such as the RSNA Trainee Prize, SIR Constantine Cope award, ECR Invest in Youth award and the prestigious PEO Foundation Award for Excellent Women in Science. Additional information can be found at the Yale Interventional Oncology Research Lab Website.
Education
Yale IR residency training in the Yale New Haven Medical Center program is the only IR training program in the state of Connecticut. Yale IR residency received continued accreditation from the ACGME in 2019. We offer three IR Internship-Residency positions per year. We are accepting IR Intern-Residency applications through ERAS/NRMP on a yearly basis. For more information about the Yale IR residency program, click here.
Yale IR Global Outreach
Yale IR is a leader in global IR, bringing minimally invasive treatment options to underserved populations worldwide. In collaboration with Emory University and Muhimbili University of Health and Allied Sciences, Yale IR has established the first accredited IR training program in sub-Saharan Africa. Before initiation of this training program there was not a single interventional radiologist in Tanzania, an East African nation with a population of nearly 60 million people. This means that many essential and life-saving procedures could not be performed. Yale IR has coordinated deployment of 14 teams to Tanzania for two-week teaching trips since 2018, overseeing more than 300 IR procedures ranging from simple biopsies to complex vascular procedures. Yale IR recognizes the important role minimally invasive treatments will play in improving medical care in Africa and is committed to making these advances available to as many people as possible. This work is supported by several institutional and national grants, including the RSNA Research & Education Foundation Derek Harwood-Nash International Scholar Grant. For more information visit Yale IR Outreach Program Website and @road2IR on Twitter, Facebook, and Instagram.
Twitter Feed
Recent Publications
2023
- Inhibiting bacterial biofilm formation by stimulating c-di-GMP regulation using citrus peel extract from Jeju Island.Kim HS, Ham SY, Ryoo HS, Kim DH, Yun ET, Park HD, Park JH. Sci Total Environ. 2023 May 10; 2023 Feb 11. PMID: 36775169.
- Percutaneous Ablation, Osteoplasty, Reinforcement, and Internal Fixation for Pain and Ambulatory Function in Periacetabular Osteolytic Malignancies.Dussik CM, Toombs C, Alder KD, Yu KE, Berson ER, Ibe IK, Li F, Lindskog DM, Friedlaender GE, Latich I, Lee FY. Radiology. 2023 Mar 14; 2023 Mar 14. PMID: 36916888.
- Impaired left-ventricular global longitudinal strain by feature-tracking cardiac MRI predicts mortality in systemic sclerosis.Feher A, Miller EJ, Peters DC, Mojibian HR, Sinusas AJ, Hinchcliff M, Baldassarre LA. Rheumatol Int. 2023 Mar 10; 2023 Mar 10. PMID: 36894756.
- Complex pathologies in a patient referred for varicose veins.Ali S, Pinto P, Huber S, Perez-Lozada JC, Attaran R, Ochoa Chaar CI. J Vasc Surg Cases Innov Tech. 2023 Mar; 2023 Jan 20. PMID: 36852313.
- Experimental VX2 Rabbit Liver Tumor Model in Carbon Tetrachloride-Induced Cirrhosis of the Liver.Santana JG, Shewarega A, Nam D, Kahl V, Madoff DC, Zhang X, Chapiro J. J Vasc Interv Radiol. 2023 Mar; 2022 Dec 5. PMID: 36473611.
- Percutaneous Chemical and Mechanical Necrosectomy for Walled-Off Pancreatic Necrosis.Ghabili K, Shaikh J, Pollak J, Elwood D, Majdalany BS, Nezami N. J Vasc Interv Radiol. 2023 Mar; 2022 Nov 21. PMID: 36423816.
- MR Imaging-Based In Vivo Macrophage Imaging to Monitor Immune Response after Radiofrequency Ablation of the Liver.Santana JG, Petukhova-Greenstein A, Gross M, Hyder F, Pekurovsky V, Gottwald LA, Boustani A, Walsh JJ, Kucukkaya AS, Malpani R, Madoff DC, Goldberg SN, Ahmed M, Joshi N, Coman D, Chapiro J. J Vasc Interv Radiol. 2023 Mar; 2022 Nov 21. PMID: 36423815.
- Acute outcomes for the full US cohort of the FLASH mechanical thrombectomy registry in pulmonary embolism.Toma C, Jaber WA, Weinberg MD, Bunte MC, Khandhar S, Stegman B, Gondi S, Chambers J, Amin R, Leung DA, Kado H, Brown MA, Sarosi MG, Bhat AP, Castle J, Savin M, Siskin G, Rosenberg M, Fanola C, Horowitz JM, Pollak JS. EuroIntervention. 2023 Feb 20. PMID: 36349702.
- Operator Learning Curve for Prostatic Artery Embolization and Its Impact on Outcomes in 296 Patients.Powell T, Rahman S, Staib L, Bhatia S, Ayyagari R. Cardiovasc Intervent Radiol. 2023 Feb; 2022 Dec 1. PMID: 36456689.
- Use of a Large-bore Thrombectomy Device for Portal Vein Thrombectomy in the Setting of Prior Transjugular Intrahepatic Portosystemic Shunt Reduction: A Report of 2 Cases.Cornman-Homonoff J, Parmar G, Perez Lozada JC, Marino AG. J Vasc Interv Radiol. 2023 Feb; 2022 Oct 23. PMID: 36283594.
- Transpleural Systemic Artery-to-Pulmonary Artery Shunts: A Potential Mimicker of Pulmonary Arteriovenous Malformations.Fish FA, Chan SM, Pollak J, Schlachter T. J Vasc Interv Radiol. 2023 Feb; 2022 Oct 23. PMID: 36283590.
- Defining textbook outcome for selective internal radiation therapy of hepatocellular carcinoma: an international expert study.Gregory J, Tselikas L, Allimant C, de Baere T, Bargellini I, Bell J, Bilbao JI, Bouvier A, Chapiro J, Chiesa C, Decaens T, Denys A, Duran R, Edeline J, Garin E, Ghelfi J, Helmberger T, Irani F, Lam M, Lewandowski R, Liu D, Loffroy R, Madoff DC, Mastier C, Salem R, Sangro B, Sze D, Vilgrain V, Vouche M, Guiu B, Ronot M. Eur J Nucl Med Mol Imaging. 2023 Feb; 2022 Oct 25. PMID: 36282299.
- Machine Learning Models for Prediction of Posttreatment Recurrence in Early-Stage Hepatocellular Carcinoma Using Pretreatment Clinical and MRI Features: A Proof-of-Concept Study.Iseke S, Zeevi T, Kucukkaya AS, Raju R, Gross M, Haider SP, Petukhova-Greenstein A, Kuhn TN, Lin M, Nowak M, Cooper K, Thomas E, Weber MA, Madoff DC, Staib L, Batra R, Chapiro J. AJR Am J Roentgenol. 2023 Feb; 2022 Aug 17. PMID: 35975886.
- Emerging Indications for Interventional Oncology: Expert Discussion on New Locoregional Treatments.Iezzi R, Gangi A, Posa A, Pua U, Liang P, Santos E, Kurup AN, Tanzilli A, Tenore L, De Leoni D, Filippiadis D, Giuliante F, Valentini V, Gasbarrini A, Goldberg SN, Meijerink M, Manfredi R, Kelekis A, Colosimo C, Madoff DC. Cancers (Basel). 2023 Jan 2; 2023 Jan 2. PMID: 36612304.
2022
- Locoregional Therapy in the Management of Intrahepatic Cholangiocarcinoma: Is There Sufficient Evidence to Guide Current Clinical Practice?Wang Y, Strazzabosco M, Madoff DC. Curr Oncol Rep. 2022 Dec; 2022 Oct 18. PMID: 36255606.